Ivy Natal
PrivateLast Round
Accelerator
Oct 27, 2020
Total Funding Raised
$250,000
Company Overview
Ivy Natal is a biotechnology company developing a novel process to create healthy human egg cells from skin cells to address infertility.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ivy Natal Comparables
Compare Ivy Natal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ovelle Bio Corp. | 91% | |
| Conception | 90% | |
| Vitra Labs | 88% | |
Ivy Natal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 27, 2020 |
Ivy Natal Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2025
Monthly visitors increased 84% MoM.
Ivy Natal Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ivy Natal's valuation, stock price, and market status.